Literature DB >> 7637033

Immune responses to plasmid DNA encoding the hepatitis C virus core protein.

L M Lagging1, K Meyer, D Hoft, M Houghton, R B Belshe, R Ray.   

Abstract

Hepatitis C virus (HCV) is a major causative agent of parenterally transmitted non-A, non-B hepatitis. The genomic region encoding the virion-associated core protein is relatively conserved among HCV strains. To generate a DNA vaccine capable of expressing the HCV core protein, the genomic region encoding amino acid residues 1 to 191 of the HCV-1 strain was amplified and cloned into an eukaryotic expression vector. Intramuscular inoculation of recombinant plasmid DNA into BALB/c mice (H-2d) generated core-specific antibody responses, lymphoproliferative responses, and cytotoxic T-lymphocyte activity. Our results suggest that the HCV core polynucleotide warrants further investigation as a potential vaccine against HCV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637033      PMCID: PMC189461     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Persistence of HCV despite antibodies to both putative envelope glycoproteins.

Authors:  D Y Chien; Q L Choo; R Ralston; R Spaete; M Tong; M Houghton; G Kuo
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

2.  Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Authors:  R Ray; A Khanna; L M Lagging; K Meyer; Q L Choo; R Ralston; M Houghton; P R Becherer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

3.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.

Authors:  A L Erickson; M Houghton; Q L Choo; A J Weiner; R Ralston; E Muchmore; C M Walker
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

Review 5.  Hepatitis viruses: changing patterns of human disease.

Authors:  R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.

Authors:  M Sedegah; R Hedstrom; P Hobart; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

7.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

Authors:  E F Fynan; R G Webster; D H Fuller; J R Haynes; J C Santoro; H L Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

Authors:  P Farci; H J Alter; D C Wong; R H Miller; S Govindarajan; R Engle; M Shapiro; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.

Authors:  M Shirai; H Okada; M Nishioka; T Akatsuka; C Wychowski; R Houghten; C D Pendleton; S M Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

Authors:  Z Q Xiang; S Spitalnik; M Tran; W H Wunner; J Cheng; H C Ertl
Journal:  Virology       Date:  1994-02-15       Impact factor: 3.616

View more
  24 in total

1.  DNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc.

Authors:  Lian-San Zhao; Shan Qin; Tao-You Zhou; Hong Tang; Li Liu; Bing-Jun Lei
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

Review 2.  Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments.

Authors:  Philip Wintermeyer; Jack R Wands
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

Review 3.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 4.  Gene vaccination for hepatitis C.

Authors:  G Inchauspé
Journal:  Springer Semin Immunopathol       Date:  1997

Review 5.  Genetic vaccines--a revolution in vaccinology?

Authors:  Z Q Xiang; S Pasquini; Z He; H Deng; Y Wang; M A Blaszczyk-Thurin; H C Ertl
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode.

Authors:  I Nakano; G Maertens; M E Major; L Vitvitski; J Dubuisson; A Fournillier; G De Martynoff; C Trepo; G Inchauspe
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene.

Authors:  S W Lee; J H Cho; Y C Sung
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.

Authors:  Yeping Sun; Jun Liu; Meng Yang; Feng Gao; Jianfang Zhou; Yoshihiro Kitamura; Bin Gao; Po Tien; Yuelong Shu; Aikichi Iwamoto; Zhu Chen; George F Gao
Journal:  J Gen Virol       Date:  2009-12-02       Impact factor: 3.891

9.  In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.

Authors:  J I Sin; J J Kim; J D Boyer; R B Ciccarelli; T J Higgins; D B Weiner
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.